Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study

Guardado en:

Detalles Bibliográficos
Publicado en:	Vaccines vol. 12, no. 8 (2024), p. 883
Autor principal:	Shoemaker, Kathryn
Otros Autores:	Soboleva, Karina, Branche, Angela, Shankaran, Shivanjali, Theodore, Deborah A, Bari, Muhammad, Ezeh, Victor, Green, Justin, Kelly, Elizabeth, Lan, Dongmei, Olsson, Urban, Senthilkumar Saminathan, Shankar, Nirmal Kumar, Villegas, Berta, Villafana, Tonya, Falsey, Ann R, Sobieszczyk, Magdalena E
Publicado:	MDPI AG
Materias:	Peru United States > US Chile Enrollments Infections Antibodies COVID-19 vaccines Severe acute respiratory syndrome coronavirus 2 Disease Decoupling Humoral immunity Safety Nucleocapsids Serology Immunity (Disease) Immunogenicity Pandemics Effectiveness Illnesses COVID-19 Thrombocytopenia Social
Acceso en línea:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!